REGISTERED CHARITY NUMBER: 326152
REPORT OF THE TRUSTEES AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
FOR THE
BRITISH ASSOCIATION OF ENDOCRINE AND THYROID SURGEONS
TRADING AS BAETS
BRITISH ASSOCIATION OF ENDOCRINE AND THYROID SURGEONS TRADING AS BAETS
CONTENTS OF THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
| Page | |
|---|---|
| Report of the Trustees | 1 |
| Independent Examiner's Report | 5 |
| Statement of Financial Activities | 6 |
| Balance Sheet | 7 |
| Notes to the Financial Statements | 8 |
| Detailed Statement of Financial Activities | 13 |
BRITISH ASSOCIATION OF ENDOCRINE AND THYROID SURGEONS TRADING AS BAETS
REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2025
The Trustees present their report together with the financial statements of the charity for the year ended 31 December 2025. The Trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).
STRUCTURE, GOVERNANCE AND MANAGEMENT
Governing document
BAETS is controlled by its governing document, a deed of trust and constitution, and operates as an unincorporated charity.
REFERENCE AND ADMINISTRATIVE DETAILS
Registered Charity number
326152
Principal address
Royal College of Surgeons 35London WC2A 3PE
Trustees
Ms F Eatock - President BAETS Mr O J Hilmi - Treasurer BAETS Ms S Fraser - Secretary BAETS Mr N Gittoes Ms K Farnell MBE
Independent Examiner
Richard M Taylor, C.A. 13 Whittingehame Drive Glasgow G12 0XT
LEGAL AND ADMINISTRATIVE DETAILS
Charity Registration
BAETS is an unincorporated charity which is governed by its constitution adopted on 7[th ] July 1982. The charity registration number is 326152.
Method of appointment or election of Trustees
Trustees with the required skillset are elected by vote by the members and confirmed at the Annual General Meeting for a term of three years. Any Trustee so appointed shall, at the end of their term in office, be eligible for re-election.
Page 1
BRITISH ASSOCIATION OF ENDOCRINE AND THYROID SURGEONS TRADING AS BAETS
REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2025
Policies adopted for the induction and training of Trustees
All new Trustees are asked to sign a statement of eligibility and are sent the following:
-
The minutes of the Trustees meetings for the previous year.
-
List of current Trustees and contact details.
-
Annual list of dates of Trustees meetings.
-
Guidance on expenses allowances.
-
The most recent Association accounts.
-
What you need to know
Risks
Trustees regularly review the major risks to which the Association is exposed, and systems have been established to mitigate those risks. External risks to the Association have led to the development of a system of regular review of investments. Internal risks are minimised through the implementation of procedures for authorisation of all transactions and funding. These procedures are periodically reviewed to ensure that they still meet the needs of the Association.
The Trustees consider that the risks to which BAETS is exposed are not of material significance.
Charity objective
BAETS membership consists of consultant and trainee surgeons with a common interest in endocrine surgery. It was formed in 1981 for the purpose of providing education and training advice in the sphere of endocrine surgery.
Activities
BAETS holds a national annual meeting where research papers for the purposes of education are presented. There is an educational forum in the form of a teaching symposium and guest speakers are invited to speak on educational topics. In the past few years BAETS has developed a series of online educational webinars to aid continuing professional development and education of its members and collaborated on educational webinars.
BAETS plays an active and key role in the formation of national guidelines for endocrine surgery and in the structure of education and examination of junior surgeons. It has had an advisory role in the future of endocrine surgery provision with regards to NHS planning at Government level. It also runs a national database for all endocrine surgery operations and results from this database are used to establish UK practice and aim to improve surgical outcomes.
BAETS supports research with direct grants, applied for in competition and before an interview panel. It also supports junior and newly appointed consultants with travel grants for educational purposes and has close links with other patient led charities such as Butterfly Thyroid Cancer Trust, AMEND and the British Thyroid Foundation.
Achievements and performance
BAETS annual scientific conference continues to thrive and is a platform for the exchange of ideas and for the continuing professional development of its members. In 2025 the conference was held in Manchester. This was a very popular meeting with wide ranging discussions on the management of head, neck and abdominal paragangliomas, Thyroid cancer and benign thyroid and parathyroid disease. Members found it a great opportunity to network and learn from each other. The Thyroid and Parathyroid masterclass in March 2025 was once again held at the RCSEd Birmingham, over two days. This was very successful and universally well received.
Page 2
BRITISH ASSOCIATION OF ENDOCRINE AND THYROID SURGEONS TRADING AS BAETS
REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2025
The UKRETS database with dashboards for recording parathyroid, adrenal and thyroid operations continues to work well for use in members self-audit and appraisal.
BAETS continues to collaborate with its European partners in the pan-European rare endocrine tumours database EUROCRINE. This aims to improve the welfare of patients with rare endocrine tumours by the learning that may follow inspection of a large cohort of patients from across Europe. Analysis of the BAETS database of endocrine operations (UKRETS) continues.
Education and research continue to be a strong focus of BAETS which offers annual educational grants to - reviewed by appropriate scientific referees.
BAETS has also been in active discussions with patient representative groups to help develop and update patient information leaflets which are available to both patients and health care professionals free of charge from the BAETS website that has also been updated to improve both visibility and functionality.
Public Benefit Statement
The constitution of BAETS is ultimately designed to promote the welfare of patients with endocrine or thyroid diseases, whether this be through research, education, training, or other means. The Trustees and Executive of BAETS are fully cognisant of this responsibility, which informs all our decision making.
As mentioned above, we publish results of surgical outcomes of BAETS members. Whilst BAETS has been commended for being at the forefront of this drive for openness amongst national surgical associations, the Trustees are aware that there are still improvements to be made, and we are looking at ways in which this information can be cost effectively disseminated.
We continue to give multiple opportunities through webinars, podcasts and our annual general meeting for thyroid, parathyroid and adrenal surgeons to ensure that they keep up to date with the latest professional developments.
BAETS continues to collaborate with the Get It Right First Time (GIRFT) project which aims to drive up standards, equalise patient access to high-quality care and share good practice across the country.
The Trustees are pleased to provide funding for research into the causes, effects, or treatments of endocrine disorders. In 2025 we continued to provide free registration to those trainees physically presenting their work at the meeting in Manchester and encouraged engagement of Allied Health professionals at the conference.
The Trustees fully recognise the importance of patient charities and organisations and work closely with them, especially around the time of our annual scientific conference and are exploring ways of making the patient experience an integral part of the annual meeting.
Provision of high-quality education and training for the next generation of endocrine and thyroid surgeons is one of BAETS key goals. To that end we support our trainees in being able to disseminate their research work thus enhancing their career development and their knowledge of endocrine disease.
Reserves Policy
It is the policy of BAETS to maintain unrestricted funds, which are the free reserves of the Association, at a level to provide sufficient cash resources to meet future expenditure. At 31 December 2025 the unrestricted funds of BAETS are £254,444 (2024: £242,084).
The Honorary Treasurer updates the Trustees on the level of reserves, and this is collectively reviewed annually. The Trustees consider that the reserves held at the year-end are sufficient to meet the future activities of the Association.
Page 3
BRITISH ASSOCIATION OF ENDOCRINE AND THYROID SURGEONS TRADING AS BAETS
REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2025
STATEMENT OF TRUSTEES' RESPONSIBILITIES
The Trustees are responsible for preparing the Report of the Trustees and the financial statements in accordance with applicable Charity law requirements. Charity law requires the Trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the Association and of the incoming resources and application of resources, including the income and expenditure for that period.
In preparing these financial statements, the Trustees are required to:
-
select suitable accounting policies and then apply them consistently;
-
observe the methods and principles in the Charity SORP;
-
make judgements and estimates that are reasonable and prudent;
-
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Association will continue in business.
The Trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the Association. They are also responsible for safeguarding the assets of the Association and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Approved by order of the Board of Trustees on 7 October 2026 and signed on its behalf by:
Mr O J Hilmi - Trustee
Page 4
BRITISH ASSOCIATION OF ENDOCRINE AND THYROID SURGEONS TRADING AS BAETS
FOR THE YEAR ENDED 31 DECEMBER 2025
Independent Examiner's Report to the Trustees of the British Association of Endocrine and Thyroid Surgeons
I report to the Trustees on my examination of the accounts of the British Association of Endocrine and Thyroid Surgeons (The Trust) for the year ended 31 December 2025.
Responsibilities and basis of report
As the Charity Trustees of the Trust, you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 20
2011 Act and in carrying out my examination I have followed all applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.
Independent examiner's statement
I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
-
1) Accounting records were not kept in respect of the Trust as required by section 130 of the Act; or
-
2) The accounts do not accord with these records; or
-
3) The accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report to enable a proper understanding of the accounts to be reached.
Richard Taylor, CA 13 Whittingehame Drive Glasgow G12 0XT
7 October 2026
Page 5
BRITISH ASSOCIATION OF ENDOCRINE AND THYROID SURGEONS TRADING AS BAETS
STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 DECEMBER 2025
| Incoming resources Income and endowments from: Charitable activities Conference income Investment income Other income Total Resources expended Expenditure on: Raising funds Charitable activities Conferences Grants and Prizes Governance Other Total Net income Net movement in funds Reconciliation of funds: Total funds brought forward Total funds carried forward |
Notes 2 3 |
2025 Total funds £ 105,935 116,899 5,052 4,574 232,460 10,070 156,337 5,000 41,213 7,480 220,100 12,360 12,360 242,084 254,444 |
2024 Total funds £ 70,748 128,299 5,919 2,076 207,042 8,999 122,144 6,069 20,386 7,304 164,902 42,140 42,140 199,944 242,084 |
|---|---|---|---|
The notes form part of these financial statements
Page 6
BRITISH ASSOCIATION OF ENDOCRINE AND THYROID SURGEONS TRADING AS BAETS
BALANCE SHEET FOR THE YEAR ENDED 31 DECEMBER 2025
| Current assets Debtors Cash at bank Creditors Amounts falling due within one year Net current assets Total assets less current liabilities Net Assets Funds Unrestricted funds Total Funds |
Notes 6 8 7 9 |
2025 Total funds £ 17,036 246,157 263,193 (8,749) 254,444 254,444 254,444 254,444 254,444 |
2024 Total funds £ 31,403 212,463 243,866 (1,782) 242,084 242,084 242,084 242,084 242,084 |
|---|---|---|---|
The financial statements were approved by the Board of Trustees and authorised for issue on 7 October 2026 and were signed on its behalf by:
Ms S Fraser Trustee
Mr O J Hilmi - Trustee
The notes form part of these financial statements
Page 7
BRITISH ASSOCIATION OF ENDOCRINE AND THYROID SURGEONS TRADING AS BAETS
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
1. ACCOUNTING POLICIES
Basis of preparing the financial statements
The financial statements of the charity, which is a public benefit entity under FRS 102, have been prepared under the historical cost convention with items recognised at cost or transaction value unless otherwise stated in the relevant note to the accounts. The accounts have been prepared in accordance with the Statement of Recommended Practice: Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019) and the Charities Act 2011.
The charity has taken advantage of the following disclosure exemptions in preparing these financial
The requirement of Section 7 Statement of Cash Flows.
Income
All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received, and the amount can be measured reliably.
Investment income is included when receivable and consists solely of bank interest.
Expenditure
Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to pay out resources and the amount of the obligation can be measured with reasonable certainty.
Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings, they have been allocated to activities on a basis consistent with the use of resources.
The charity has creditors which are measured at settlement amounts.
Allocation and apportionment of costs
Support costs are allocated 100% towards charitable activities which includes governance costs.
Taxation
The charity is recognised by HMRC as exempt from taxation on its charitable activities.
Fund accounting
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the Trustees.
Volunteers
In accordance with FRS 102 and the Charities SORP (FRS 102), the economic contribution of general volunteers is not recognised in the financial statements due to inaccurate measurement bases.
continued...
Page 8
BRITISH ASSOCIATION OF ENDOCRINE AND THYROID SURGEONS TRADING AS BAETS
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
| 2. Incoming resources: 2025 £ Charitable activities member subscriptions 38,213 Charitable activities strategic partnerships 67,722 Conference income 116,899 1 Investment income 5,052 Other income masterclass and HQIP 4,574 Total 232,460 2 3. Resources expended: 2025 Expenditure on raising funds: £ Membership administration fees 10,070 Expenditure on charitable activities: Conferences 156,337 1 Grants and Prizes 5,000 Support costs - governance 41,213 Support costs - other 7,480 210,030 1 4. Details of certain items of expenditure: 2025 £ Independent examiners fees 1,100 |
2024 £ 40,748 30,000 28,299 5,919 2,076 |
|---|---|
07,042 |
|
| 2024 £ 8,999 |
|
22,144 6,069 20,386 7,304 55,903 |
|
| 2024 £ 1,100 |
continued...
Page 9
BRITISH ASSOCIATION OF ENDOCRINE AND THYROID SURGEONS TRADING AS BAETS
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
5. Trustees Remuneration and Benefits:
There were no Trustees' remuneration or other benefits for the year ended 31 December 2025 nor for the year ended 31 December 2024.
Trustees' expenses
Expenses totalling £175 were paid to one Trustee during the year (2024 - £317; 1 Trustee).
| At 31 December 2025 there were no outstanding expenses due to any charity expenditure incurred by a Trustee. 6. Debtors and prepayments: Trade debtors Prepayments and accrued income Total 7. Creditors and accruals: Trade creditors Accrued expenses Total 8. Cash at bank and in hand: Cash at bank |
Trustee. (2024 - £nil) for 2025 £ 1,230 2024 £ 5,400 15,806 26,003 17,036 31,403 2025 £ - 2024 £ - 8,749 1,782 8,749 1,782 2025 £ 246,157 2024 £ 212,463 |
|---|---|
continued...
Page 10
BRITISH ASSOCIATION OF ENDOCRINE AND THYROID SURGEONS TRADING AS BAETS
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
| 9. Movement in Funds At 01/01/25 Unrestricted funds £ General fund 242,084 Total funds 242,084 Net movement in funds, included in the above are as follows: Incoming resources Unrestricted funds £ General fund 232,460 Movement in funds 232,460 Comparatives for Movement in funds At 01/01/24 Unrestricted funds £ General fund 199,944 Total funds 199,944 Comparative net movement in funds, included in the above are as follows: Incoming resources Unrestricted funds £ General fund 207,042 Movement in funds 207,042 |
Net movement in funds At 31/12/25 £ £ 12,360 254,444 12,360 254,444 Resources expended Movement in funds £ £ (220,100) 12,360 (220,100) 12,360 Net movement in funds At 31/12/24 £ £ 42,140 242,084 42,140 242,084 Resources expended Movement in funds £ £ (164,902) 42,140 (164,902) 42,140 |
|---|---|
continued...
Page 11
BRITISH ASSOCIATION OF ENDOCRINE AND THYROID SURGEONS TRADING AS BAETS
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
9. Movement in funds - continued
A current year 12 months and prior year 12 months combined position is as follows:
| Unrestricted funds General fund Total funds |
At Net movement 01/01/24 in funds £ £ 199,944 54,500 199,944 54,500 |
At 31/12/25 £ 254,444 254,444 |
|---|---|---|
A current year 12 months and prior year 12 months combined net movement in funds included in the above is as follows:
| Incoming | Resources | Movement | |
|---|---|---|---|
| resources | expended | in funds | |
| £ | £ | £ | |
| Unrestricted funds | |||
| General fund | 439,501 | (385,001) | 54,500 |
| Movement in funds | 439,501 | (385,001) | 54,500 |
10. Related party disclosures
There were no related party transactions for the year ended 31 December 2025.
Page 12
BRITISH ASSOCIATION OF ENDOCRINE AND THYROID SURGEONS TRADING AS BAETS
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
| 2025 | 2024 | |
|---|---|---|
| £ | £ | |
| INCOME AND ENDOWMENTS | ||
| Main charitable activities | ||
| Subscriptions | 38,213 | 40,748 |
| Strategic Partner income | 67,722 | 30,000 |
| Investment income | ||
| Deposit account interest | 5,052 | 5,919 |
| Charitable activities | ||
| Conference income | 116,899 | 128,299 |
| Other income | ||
| Masterclass & BJS | 4,574 | 2,076 |
| Total incoming resources | 232,460 | 207,042 |
| EXPENDITURE | ||
| Raising donations and legacies | ||
| Membership administration fees | 10,070 | 8,999 |
| Charitable activities | ||
| Conference costs | 156,337 | 122,144 |
| Grants and Prizes | 5,000 | 6,069 |
| 161,337 | 128,213 | |
| Other | ||
| Eurocrine research | 867 | 884 |
| Dendrite research | 6,613 | 6,420 |
| 7,480 | 7,304 | |
| Support costs | ||
| Governance | ||
| Insurance | 1,320 | 2,178 |
| Accountancy, bookkeeping & legal | 3,842 | 3,733 |
| BJS subscriptions | 2,600 | - |
| Sundry expenses | 557 | - |
| Meeting costs | 15,543 | - |
| Administration | 12,988 | 8,078 |
| Computer costs | 4,363 | 6,397 |
| 41,213 | 20,386 | |
| Total resources expended | 220,100 | 164,902 |
| Net income | 12,360 | 42,140 |
This page does not form part of the financial statements
Page 13